Skip to main content
Signal8

Genenta Science S.p.A. (SAEN)

Sector: Biological Products, (No Diagnostic Substances)

Industry: Conglomerates

Genenta Science S.p.A. logo

Genenta Science S.p.A.

NASDAQ:SAENIndustrials
-3.83%$0.5770
CLOSED
AH$0.6800+17.85%vs close
Mkt Cap$27.82M
EV-
Float15.69M
O/S48.22M
VOL46K sh
$ Vol$28K
RVOL0.33×
Inst Own-
SI0.5%
Net Cash/Sh-
EarningsMar 3 · in 4mo
Dilution
Genenta Science S.p.A. logoNASDAQ:SAENClosed$0.5770-3.83%
Historical Data
DateOpenHighLowCloseVolume
Nov 17, 20260.67980.67980.57190.577046,490
Nov 16, 20260.63000.63000.59000.600036,367
Nov 13, 20260.62410.67010.60050.649818,860
Nov 12, 20260.70000.70000.62040.624018,719
Nov 11, 20260.70020.71490.66480.68008,487
Nov 10, 20260.74700.74700.68010.717932,825
Nov 9, 20260.67690.72060.62500.680125,233
Nov 6, 20260.64500.71990.59990.6650107,604
Nov 5, 20260.66910.68320.55530.6497158,708
Nov 4, 20260.78000.80000.66000.7000189,888
Nov 3, 20260.83590.99000.81890.9850337,503
Nov 2, 20260.66110.87000.66110.81661,575,056
Oct 30, 20260.62000.63650.60000.618367,198
Oct 29, 20260.59970.62000.58010.6200153,196
Oct 28, 20260.58200.63000.58200.605042,193
Oct 27, 20260.63300.63690.59100.618218,900
Oct 26, 20260.61500.63400.59550.624428,856
Oct 23, 20260.63990.63990.63000.630013,372
Oct 22, 20260.66100.66100.63010.630136,968
Oct 21, 20260.61000.65980.61000.640036,764
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
Not available
Ratings Distribution
BUY
1
HOLD
0
SELL
0
TOTAL1
Insider Trades
InsiderTypeShares
Galimi Francesco profile photoGalimi FrancescoGrant/Award20.0K
PARACCHI GIACOMOANTONIO profile photoPARACCHI GIACOMOANTONIOGrant/Award20.0K
Sharei Armon profile photoSharei ArmonGrant/Award20.0K
Mutti Miguel Maria profile photoMutti Miguel MariaGrant/Award20.0K
SLANSKY RICHARD B profile photoSLANSKY RICHARD BGrant/Award80.0K
Pierluigi Paracchi profile photoPierluigi ParacchiGrant/Award100.0K
Shareholders
--
Institutional
(14)
--
Insiderⓘ
(2)
--
5%+ Owners
(2)
--
Unattributed (incl. retail)ⓘ
Top Shareholders
NameShares%
Globe 2017 S.r.l. logo
Globe 2017 S.r.l.
· joint filing· may incl. warrants· filed Oct 2026
5.5M11.5%
Pierluigi Paracchi logo
Pierluigi Paracchi
· may incl. warrants· filed Jan 2026
2.3M9.8%
Eurizon Capital SGR S.p.A. logo
Eurizon Capital SGR S.p.A.
360.0K--
ALLIANZ SE logo
ALLIANZ SE
234.1K--
AlTi Global, Inc. logo
AlTi Global, Inc.
200.3K--
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
191.0K--
BNP PARIBAS FINANCIAL MARKETS logo
BNP PARIBAS FINANCIAL MARKETS
47.0K--
JANE STREET GROUP, LLC logo
JANE STREET GROUP, LLC
42.1K--
Mutti Miguel Maria profile photo
Mutti Miguel Maria
Director
33.3K--
TWO SIGMA SECURITIES, LLC logo
TWO SIGMA SECURITIES, LLC
29.2K--
Sources: 13F, Form 4, 13D/13G
Insiders & Institutional Holders
About

Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused on pioneering hematopoietic stem cell gene therapies to combat solid tumors.

Its primary therapeutic candidate, Temferon, is currently undergoing Phase 1/2a clinical evaluation. This innovative therapy is being developed to treat glioblastoma multiforme, specifically targeting patients whose tumors exhibit an unmethylated MGMT gene promoter. Beyond this, Genenta Science is exploring Temferon's potential application in various other solid tumor types, including locally advanced hepatocellular carcinoma and intra-hepatic cholangiocarcinoma. Established in 2014, the company maintains its headquarters in Milan, Italy.

Key Metrics
Market Cap$27.82M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 48.22M shares outstanding

SectorIndustrials
IndustryAerospace & Defense
ExchangeNASDAQ
CountryITIT
IPO DateDec 15, 2021
Shares Outstanding48.22M
Authorized Shares
Float15.69M
SEC Float (non-affiliate)16.92M
52-Week Range
$0.5500$2.58
$0.5770(1st percentile)
Volume
Average Daily Volume141.25K
46.49K today vs 141.25K avg(-67%)

30d Avg

141.25K

60d Avg

102.04K

90d Avg

85.98K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

Signal8's dilution snapshot of SAEN as of Dec 31, 2025 records 1 outstanding warrant series, from SEC filings. Genenta Science S.p.A. (NASDAQ: SAEN) traded at $0.5770 on Nov 17, 2026, down 3.83% from the previous close of $0.6000. 52-week range: $0.5500 to $2.58. The company is in the Industrials sector (Aerospace & Defense).